2025-04-08 - Analysis Report
## Schrodinger Inc. (SDGR) Stock Review

**0. Key Figures:**

* **Cumulative Return (SDGR):** -52.99%
* **Cumulative Return (VOO):** 27.34%
* **Return Difference:** -80.3%  (SDGR underperformed VOO by 80.3%)
* **Relative Divergence:** 18.4% (This indicates SDGR's underperformance is relatively lower than the historical minimum and maximum divergence)
* **Current Price:** $18.21
* **5-day MA:** $18.77
* **20-day MA:** $21.06
* **60-day MA:** $22.33
* **RSI:** 24.03 (Oversold territory)
* **PPO:** -1.59 (Bearish signal)
* **Market Risk Indicator (MRI):** 0.48 (High risk)
* **Expected Return (Long-term):** -262.3% (Significant underperformance compared to S&P 500 over the long term, based on provided data)


**1. Company Overview & Performance Comparison:**

Schrodinger Inc. is a company that uses advanced computational platforms to predict drug efficacy and efficiency.  The stock has significantly underperformed the S&P 500 (VOO) over the analyzed period, showing a cumulative return of -52.99% compared to VOO's 27.34%.  The provided data reveals that this underperformance is relatively substantial, though less extreme than the minimum observed historical difference.

**Alpha/Beta Analysis:**

The alpha and beta values exhibit considerable volatility across the provided periods.  While beta consistently remains above 1, suggesting higher volatility than the market, alpha fluctuates between slightly positive and negative, indicating inconsistent outperformance or underperformance relative to the market benchmark.  The high beta suggests significant market risk. The negative CAGR throughout many of the periods further supports poor performance.

| Year       | CAGR   | MDD    | Alpha  | Beta | Cap(B) |
|------------|--------|--------|--------|-------|--------|
| 2020-2022  | -72.0% | 61.3%  | -0.93% | 0.1   | 1.4    |
| 2021-2023  | -79.0% | 61.3%  | -100.0%| -0.0  | 2.6    |
| 2022-2024  | 2.0%   | 73.5%  | -18.0% | -0.0  | 1.4    |
| 2023-2025  | -3.0%   | 73.5%  | -17.0% | -0.2  | 1.3    |


**2. Recent Price Movement:**

The current price of SDGR is $18.21, which is below all three moving averages (5-day, 20-day, and 60-day), indicating a downtrend. The recent 1% increase from the previous close may be a temporary rebound.

**3. Technical Indicators and Divergence:**

The RSI value of 24.03 is well below the oversold level of 30, suggesting that the stock is currently oversold and a potential bounce might occur. However, the negative PPO value (-1.59) confirms bearish momentum. The recent increase in relative divergence (+8.5) indicates a short-term upward price movement but is short-term in nature. The MRI value of 0.48 suggests a high-risk investment. The provided 'change' value (1.0) suggests a recent 1% price increase, which should be considered in conjunction with other indicators, though not necessarily indicative of a significant market event. The extremely negative expected return (-262.3%) paints a grim picture for future performance.

**4. Recent Earnings Analysis:**

The provided earnings data shows consistent negative EPS and relatively flat revenues.  This points to a company struggling with profitability.

| Date       | EPS     | Revenue     |
|------------|---------|-------------|
| 2024-11-12 | -0.52   | $0.04 B     |
| 2024-07-31 | -0.74   | $0.05 B     |
| 2024-05-01 | -0.76   | $0.04 B     |
| 2023-11-01 | -0.86   | $0.04 B     |
| 2024-11-12 | -0.86   | $0.04 B     |


**5. Financial Information:**

The financial data reflects the struggles highlighted in the earnings analysis. While revenue shows some growth, Profit Margins and ROE remain significantly negative, indicating ongoing financial difficulties.  The decreasing equity also suggests a worsening financial situation.

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2024-12-31 | $0.09B     | 72.61%        |
| 2024-09-30 | $0.04B     | 50.24%        |
| 2024-06-30 | $0.05B     | 66.20%        |
| 2024-03-31 | $0.04B     | 51.61%        |
| 2023-12-31 | $0.07B     | 77.64%        |


**Capital and Profitability:**

| Quarter    | Equity     | ROE           |
|------------|------------|---------------|
| 2024-12-31 | $0.42B     | -9.54%        |
| 2024-09-30 | $0.45B     | -8.49%        |
| 2024-06-30 | $0.47B     | -11.40%       |
| 2024-03-31 | $0.51B     | -10.65%       |
| 2023-12-31 | $0.55B     | -5.59%        |


**6. Overall Analysis:**

SDGR exhibits significant underperformance compared to the S&P 500, displaying consistent negative returns and concerning financial metrics.  While some short-term indicators might suggest a potential bounce, the overall picture is bearish.  The negative expected return, consistent negative earnings, and declining equity paint a concerning picture for long-term investors.  Further investigation into the company's strategic direction and operational efficiency is warranted before considering any investment.  The high risk profile, as indicated by the MRI, should be carefully considered.  A long-term investment strategy at this point carries substantial risk given the current performance and financial outlook.
